Financial statements Memopharm
Balance sheet of Memopharm
Company age:
Age:
10 y. 7 m. 26 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of MEMOPHARM
|
Year
|
2018
|
2019
|
2020
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 2 691 622,47 | 3 022 108,61 | 4 175 277,82 | 5 473 168,95 | 6 143 126,18 |
| A. Fixed assets | 17 604,55 | 12 927,55 | 12 927,55 | 12 927,55 | 13 834,06 |
| B. Current assets | 2 674 017,92 | 3 009 181,06 | 4 162 350,27 | 5 460 241,40 | 6 129 292,12 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 691 622,47 | 3 022 108,61 | 4 175 277,82 | 5 473 168,95 | 6 143 126,18 |
| A. Equity | 969 745,28 | 1 384 532,14 | 2 079 491,99 | 4 158 620,18 | 4 931 692,28 |
| B. Liabilities and provisions for liabilities | 1 721 877,19 | 1 637 576,47 | 2 095 785,83 | 1 314 548,77 | 1 211 433,90 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 721 877,19 | 1 637 576,47 | 2 095 785,83 | 1 314 548,77 | 1 211 433,90 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.